Copyright © Philip M. Parker, INSEAD. Terms of Use.
| Domain | Definition |
Health | Studies performed to evaluate the safety of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques in healthy subjects and to determine the safe dosage range (if appropriate). These tests also are used to determine pharmacologic and pharmacokinetic properties (toxicity, metabolism, absorption, elimination, and preferred route of administration). They involve a small number of persons and usually last about 1 year. This concept includes phase I studies conducted both in the U.S. and in other countries. (references) |
Source: compiled by the editor from various references; see credits. | |
Hexadecimal (or equivalents, 770AD-1900s) (references)43 4C 49 4E 49 43 41 4C 54 52 49 41 4C 53 2C 50 48 41 53 45 49 |
| Leonardo da Vinci (1452-1519; backwards) (references)
|
Binary Code (1918-1938, probably earlier) (references)01000011 01001100 01001001 01001110 01001001 01000011 01000001 01001100 00100000 01010100 01010010 01001001 01000001 01001100 01010011 00101100 00100000 01010000 01001000 01000001 01010011 01000101 00100000 01001001 |
HTML Code (1990) (references)C L I N I C A L   T R I A L S ,   P H A S E   I |
ISO 10646 (1991-1993) (references)0043 004C 0049 004E 0049 0043 0041 004C 0054 0052 0049 0041 004C 0053 002C 0050 0048 0041 0053 0045 0049 |
Encryption (beginner's substitution cypher): (references)374643484337354625452433546531425042355339243 |
| 1. Orthography 2. Bibliography |
Copyright © Philip M. Parker, INSEAD. Terms of Use.
